Additive Therapeutic Effects of Mesenchymal Stem Cells and IL-37 for Systemic Lupus Erythematosus

BACKGROUND: Although mesenchymal stem cells (MSCs) might offer a promising strategy for treating SLE, their immunoregulatory plasticity makes their therapeutic effects unpredictable. Whether overexpressing IL-37, an IL-1 family member with immunosuppressive activity, might enhance the therapeutic ef...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Soc Nephrol
Egile Nagusiak: Xu, Jianyong, Chen, Jieting, Li, Wenlei, Lian, Wei, Huang, Jieyong, Lai, Baoyu, Li, Lingyun, Huang, Zhong
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Nephrology 2020
Gaiak:
Basic Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935004/
https://ncbi.nlm.nih.gov/pubmed/31604808
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2019050545
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak